Published in J Clin Exp Neuropsychol on June 25, 2012
Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. J Neurovirol (2012) 1.03
Host genetic factors predisposing to HIV-associated neurocognitive disorder. Curr HIV/AIDS Rep (2014) 0.88
A Cohort Pilot Study on HIV-Associated Neuropsychological Impairments in Hemophilia Patients. Front Hum Neurosci (2015) 0.85
Select neurocognitive impairment in HIV-infected women: associations with HIV viral load, hepatitis C virus, and depression, but not leukocyte telomere length. PLoS One (2014) 0.83
Is There Evidence for Neurocognitive Dysfunctions in Patients with Postnatal HIV Infection? A Review on the Cohort of Hemophilia Patients. Front Hum Neurosci (2014) 0.82
Modeling deficits in attention, inhibition, and flexibility in HAND. J Neuroimmune Pharmacol (2014) 0.81
Human immunodeficiency virus has similar effects on brain volumetrics and cognition in males and females. J Neurovirol (2015) 0.78
Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention - A Comparison with Parkinson's Disease. Neuropsychol Rev (2015) 0.78
White matter deficits assessed by diffusion tensor imaging and cognitive dysfunction in psychostimulant users with comorbid human immunodeficiency virus infection. BMC Res Notes (2015) 0.77
Diffusion tensor MR imaging of white matter integrity in HIV-positive patients with planning deficit. Neuroradiology (2015) 0.76
Intellectual Impairment in Patients with Newly Diagnosed HIV Infection in Southwestern Nigeria. Biomed Res Int (2015) 0.75
Physical function, grip strength and frailty in people living with HIV in sub-Saharan Africa: systematic review. Trop Med Int Health (2017) 0.75
Impairments in Component Processes of Executive Function and Episodic Memory in Alcoholism, HIV Infection, and HIV Infection with Alcoholism Comorbidity. Alcohol Clin Exp Res (2016) 0.75
Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1. J Neurovirol (2016) 0.75
Serotonin-Related Gene Polymorphisms and Asymptomatic Neurocognitive Impairment in HIV-Infected Alcohol Abusers. Genet Res Int (2016) 0.75
Everyday functional ability in HIV and methamphetamine dependence. Drug Alcohol Depend (2017) 0.75
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc (2004) 6.64
The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1995) 5.38
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol (2004) 5.18
Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS (2004) 5.04
The determinants of physical activity and exercise. Public Health Rep (1985) 4.73
Adult clinical neuropsychology: lessons from studies of the frontal lobes. Annu Rev Psychol (2002) 2.89
A multimodal assessment of driving performance in HIV infection. Neurology (2004) 2.81
A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc (2002) 2.64
Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci (1994) 2.59
Prospective memory in HIV-1 infection. J Clin Exp Neuropsychol (2006) 1.99
HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology (2008) 1.99
Dissociating the role of the medial and lateral anterior prefrontal cortex in human planning. Proc Natl Acad Sci U S A (2000) 1.97
Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS (1999) 1.89
Action (verb) fluency: test-retest reliability, normative standards, and construct validity. J Int Neuropsychol Soc (2005) 1.65
Frontal and parietal participation in problem solving in the Tower of London: fMRI and computational modeling of planning and high-level perception. Neuropsychologia (2003) 1.64
Characteristics of prospective memory deficits in HIV-seropositive substance-dependent individuals: preliminary observations. J Clin Exp Neuropsychol (2007) 1.60
Predictors of employment of men with HIV/AIDS: a longitudinal study. Psychosom Med (2004) 1.54
The shifting patterns of HIV encephalitis neuropathology. Neurotox Res (2005) 1.36
Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life. Arch Clin Neuropsychol (2000) 1.24
Variable patterns of neuropsychological performance in HIV-1 infection. J Clin Exp Neuropsychol (2008) 1.23
The relationship between employment and neuropsychological impairment in HIV infection. J Int Neuropsychol Soc (1999) 1.15
Is prospective memory a dissociable cognitive function in HIV infection? J Clin Exp Neuropsychol (2010) 1.12
Neurocognition, health-related reading literacy, and numeracy in medication management for HIV infection. AIDS Patient Care STDS (2010) 1.09
HIV-associated episodic memory impairment: evidence of a possible differential deficit in source memory for complex visual stimuli. J Neuropsychiatry Clin Neurosci (2009) 1.09
Planning abilities and the Tower of London: is this task measuring a discrete cognitive function? J Clin Exp Neuropsychol (2004) 1.06
Nature of depression in patients with HIV/AIDS. Aust N Z J Psychiatry (2005) 1.06
Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis. Neuropsychology (2003) 1.05
HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies. Curr Neurol Neurosci Rep (2008) 1.04
Discriminant validity and neuroanatomical correlates of rule monitoring in frontotemporal dementia and Alzheimer's disease. Neuropsychologia (2007) 1.02
Planning and problem solving: from neuropsychology to functional neuroimaging. J Physiol Paris (2006) 1.01
Protocol for the ADDITION-Plus study: a randomised controlled trial of an individually-tailored behaviour change intervention among people with recently diagnosed type 2 diabetes under intensive UK general practice care. BMC Public Health (2011) 1.01
Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. HIV Med (2006) 0.90
Neuropsychological deficits in tests of executive function in asymptomatic and symptomatic HIV-1 seropositive men. Psychol Med (1995) 0.88
Working memory deficits in HIV-seropositive drug users. J Int Neuropsychol Soc (1997) 0.86
Deconstructing the tower: parameters and predictors of problem difficulty on the Tower of London task. Brain Cogn (2010) 0.86
A computational approach to control in complex cognition. Brain Res Cogn Brain Res (2002) 0.81
Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons. J Neuropsychiatry Clin Neurosci (2011) 0.81
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol (2008) 6.91
The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc (2004) 6.64
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol (2004) 5.18
Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol (2004) 4.90
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev (2007) 3.57
Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc (2004) 3.21
Motivations associated with methamphetamine use among HIV+ men who have sex with men. J Subst Abuse Treat (2002) 3.13
Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol (2004) 3.12
Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol (2010) 2.91
Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev (2009) 2.86
Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry (2005) 2.34
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS (2011) 2.31
Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol (2002) 2.28
Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol (2004) 2.22
Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis (2003) 2.16
Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS (2006) 2.13
Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J Neurovirol (2007) 2.03
Prospective memory in HIV-1 infection. J Clin Exp Neuropsychol (2006) 1.99
HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology (2008) 1.99
Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memory. J Int Neuropsychol Soc (2009) 1.94
Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology (2013) 1.88
Sleep in spousal caregivers of people with Alzheimer's disease. Sleep (2005) 1.83
Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol (2006) 1.82
Female methamphetamine users: social characteristics and sexual risk behavior. Women Health (2004) 1.81
Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS (2002) 1.78
Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. J Clin Exp Neuropsychol (2011) 1.73
The context of sexual risk behavior among heterosexual methamphetamine users. Addict Behav (2004) 1.67
Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS (2010) 1.66
Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Arch Neurol (2004) 1.65
Action (verb) fluency: test-retest reliability, normative standards, and construct validity. J Int Neuropsychol Soc (2005) 1.65
Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol (2008) 1.64
Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis (2007) 1.63
Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol (2005) 1.62
A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology (2013) 1.62
Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain (2006) 1.60
Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management? Arch Clin Neuropsychol (2008) 1.59
Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV. Arch Clin Neuropsychol (2007) 1.58
Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol (2011) 1.57
White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol (2009) 1.57
A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men. Drug Alcohol Depend (2004) 1.57
Two-year prospective study of major depressive disorder in HIV-infected men. J Affect Disord (2007) 1.56
The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS (2005) 1.55
Depression and distress predict time to cardiovascular disease in dementia caregivers. Health Psychol (2007) 1.55
Incident major depression does not affect neuropsychological functioning in HIV-infected men. J Int Neuropsychol Soc (2007) 1.54
Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS (2004) 1.53
Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDS (2013) 1.51
The 50 and 100-item short forms of the Paced Auditory Serial Addition Task (PASAT): demographically corrected norms and comparisons with the full PASAT in normal and clinical samples. J Clin Exp Neuropsychol (2003) 1.51
Impulsivity and methamphetamine use. J Subst Abuse Treat (2005) 1.50
Psychometric characteristics of the memory for intentions screening test. Clin Neuropsychol (2008) 1.50
Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease. Cogn Behav Neurol (2006) 1.47
Low atazanavir concentrations in cerebrospinal fluid. AIDS (2009) 1.45
Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer's disease. J Am Geriatr Soc (2006) 1.44
The semantic relatedness of cue-intention pairings influences event-based prospective memory failures in older adults with HIV infection. J Clin Exp Neuropsychol (2009) 1.37
Binge use of methamphetamine among HIV-positive men who have sex with men: pilot data and HIV prevention implications. AIDS Educ Prev (2003) 1.35
Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology (2005) 1.33
Depression and suicidality in HIV/AIDS in China. J Affect Disord (2006) 1.32
Effect of Alzheimer caregiving stress and age on frailty markers interleukin-6, C-reactive protein, and D-dimer. J Gerontol A Biol Sci Med Sci (2006) 1.32
Increased Framingham Coronary Heart Disease Risk Score in dementia caregivers relative to non-caregiving controls. Gerontology (2008) 1.31
Construct validity of Hopkins Verbal Learning Test-Revised component process measures in an HIV-1 sample. Arch Clin Neuropsychol (2005) 1.31
Action (verb) fluency predicts dependence in instrumental activities of daily living in persons infected with HIV-1. J Clin Exp Neuropsychol (2006) 1.29
The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One (2012) 1.27
Neurocognitive consequences of HIV infection in older adults: an evaluation of the "cortical" hypothesis. AIDS Behav (2011) 1.27
Neurocognitive functioning in acute or early HIV infection. J Neurovirol (2010) 1.27
Effects of alcoholism and gender on brain metabolism. Am J Psychiatry (2003) 1.25
Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol (2003) 1.22
Synergistic effects of HIV infection and older age on daily functioning. J Acquir Immune Defic Syndr (2012) 1.21
Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug Alcohol Depend (2004) 1.21
The role of prospective memory in medication adherence: a review of an emerging literature. J Behav Med (2011) 1.21
Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care (2012) 1.21
Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir Immune Defic Syndr (2013) 1.21
Sexual compulsivity in a sample of HIV-positive methamphetamine-using gay and bisexual men. AIDS Behav (2006) 1.20
Psychiatric context of acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: IV. AIDS Behav (2009) 1.20
Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND). AIDS Behav (2012) 1.19
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV. J Antimicrob Chemother (2010) 1.19
Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS Behav (2006) 1.19
A differential deficit in time- versus event-based prospective memory in Parkinson's disease. Neuropsychology (2011) 1.18
Assessing cognitive change in Parkinson's disease: development of practice effect-corrected reliable change indices. Arch Clin Neuropsychol (2007) 1.18
Lithium improves HIV-associated neurocognitive impairment. AIDS (2006) 1.16
Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr (2011) 1.16
A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals. J Neuroimmune Pharmacol (2013) 1.15